New insulins and other possible therapeutic approaches

被引:3
作者
Johannesen, J
Petersen, KF
Berger, M
Binder, C
机构
[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510
[2] UNIV DUSSELDORF,D-4000 DUSSELDORF,GERMANY
关键词
D O I
10.1007/BF03168195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:B89 / B93
页数:5
相关论文
共 10 条
  • [1] INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-I TREATMENT IN THE ADOLESCENT WITH INSULIN-DEPENDENT DIABETES-MELLITUS
    DUNGER, DB
    CHEETHAM, TD
    CROWNE, EC
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (10): : 119 - 123
  • [2] Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM
    Kolterman, OG
    Schwartz, S
    Corder, C
    Levy, B
    Klaff, L
    Peterson, J
    Gottlieb, A
    [J]. DIABETOLOGIA, 1996, 39 (04) : 492 - 499
  • [3] ULTRASOUND-MEDIATED TRANSDERMAL PROTEIN DELIVERY
    MITRAGOTRI, S
    BLANKSCHTEIN, D
    LANGER, R
    [J]. SCIENCE, 1995, 269 (5225) : 850 - 853
  • [4] Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes
    Moses, AC
    Young, SCJ
    Morrow, LA
    OBrien, M
    Clemmons, DR
    [J]. DIABETES, 1996, 45 (01) : 91 - 100
  • [5] Evidence based medicine: What it is and what it isn't - It's about integrating individual clinical expertise and the best external evidence
    Sackett, DL
    Rosenberg, WMC
    Gray, JAM
    Haynes, RB
    Richardson, WS
    [J]. BRITISH MEDICAL JOURNAL, 1996, 312 (7023) : 71 - 72
  • [6] THOMPSON RG, 1996, DIABETES S2, V45, pA222
  • [7] C-peptide revisited - New physiological effects and therapeutic implications
    Wahren, J
    Johansson, BL
    WallbergHenriksson, H
    Linde, B
    FernqvistForbes, E
    Zierath, JR
    [J]. JOURNAL OF INTERNAL MEDICINE, 1996, 240 (03) : 115 - 124
  • [8] Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity
    Young, AA
    Wang, MW
    Gedulin, B
    Rink, TJ
    Pittner, R
    Beaumont, K
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (12): : 1581 - 1589
  • [9] BENEFICIAL METABOLIC EFFECTS OF INSULIN-LIKE GROWTH-FACTOR-I IN PATIENTS WITH SEVERE INSULIN-RESISTANT DIABETES TYPE-A
    ZENOBI, PD
    GLATZ, Y
    KELLER, A
    GRAF, S
    JAEGGIGROISMAN, SE
    RIESEN, WF
    SCHOENLE, EJ
    FROESCH, ER
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (03) : 251 - 257
  • [10] Insulin lispro in CSII - Results of a double-blind crossover study
    Zinman, B
    Tildesley, H
    Chiasson, JL
    Tsui, E
    Strack, T
    [J]. DIABETES, 1997, 46 (03) : 440 - 443